BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19751731)

  • 1. C-terminal binding proteins (CtBPs) attenuate KLF4-mediated transcriptional activation.
    Liu G; Zheng H; Ai W
    FEBS Lett; 2009 Oct; 583(19):3127-32. PubMed ID: 19751731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the PLDLS-binding cleft region of CtBP1 in recruitment of core and auxiliary components of the corepressor complex.
    Kuppuswamy M; Vijayalingam S; Zhao LJ; Zhou Y; Subramanian T; Ryerse J; Chinnadurai G
    Mol Cell Biol; 2008 Jan; 28(1):269-81. PubMed ID: 17967884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation is involved in the pathogenesis of osteoarthritis by regulating
    Sun X; Xiao L; Chen J; Chen X; Chen X; Yao S; Li H; Zhao G; Ma J
    Int J Biol Sci; 2020; 16(6):994-1009. PubMed ID: 32140068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZNF750 interacts with KLF4 and RCOR1, KDM1A, and CTBP1/2 chromatin regulators to repress epidermal progenitor genes and induce differentiation genes.
    Boxer LD; Barajas B; Tao S; Zhang J; Khavari PA
    Genes Dev; 2014 Sep; 28(18):2013-26. PubMed ID: 25228645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Krüppel-like zinc finger protein Gli-similar 2 (Glis2) represses transcription through interaction with C-terminal binding protein 1 (CtBP1).
    Kim SC; Kim YS; Jetten AM
    Nucleic Acids Res; 2005; 33(21):6805-15. PubMed ID: 16326862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperative transcriptional activation by Klf4, Meis2, and Pbx1.
    Bjerke GA; Hyman-Walsh C; Wotton D
    Mol Cell Biol; 2011 Sep; 31(18):3723-33. PubMed ID: 21746878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CtBP family protein isoforms in breast cancer and their role in chemoresistance.
    Birts CN; Harding R; Soosaipillai G; Halder T; Azim-Araghi A; Darley M; Cutress RI; Bateman AC; Blaydes JP
    Biol Cell; 2010 Jan; 103(1):1-19. PubMed ID: 20964627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-terminal binding proteins: central players in development and disease.
    Stankiewicz TR; Gray JJ; Winter AN; Linseman DA
    Biomol Concepts; 2014 Dec; 5(6):489-511. PubMed ID: 25429601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of CtBP1 in the transcriptional activation of the MDR1 gene in human multidrug resistant cancer cells.
    Jin W; Scotto KW; Hait WN; Yang JM
    Biochem Pharmacol; 2007 Sep; 74(6):851-9. PubMed ID: 17662696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KLF4 and PBX1 directly regulate NANOG expression in human embryonic stem cells.
    Chan KK; Zhang J; Chia NY; Chan YS; Sim HS; Tan KS; Oh SK; Ng HH; Choo AB
    Stem Cells; 2009 Sep; 27(9):2114-25. PubMed ID: 19522013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transrepression and transactivation roles of CtBPs in the pathogenesis of different diseases.
    Chen Z
    J Mol Med (Berl); 2021 Oct; 99(10):1335-1347. PubMed ID: 34196767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transcriptional corepressor CtBP: a foe of multiple tumor suppressors.
    Chinnadurai G
    Cancer Res; 2009 Feb; 69(3):731-4. PubMed ID: 19155295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of HIC1 target genes by CtBP and NuRD, via an acetylation/SUMOylation switch, in quiescent versus proliferating cells.
    Van Rechem C; Boulay G; Pinte S; Stankovic-Valentin N; Guérardel C; Leprince D
    Mol Cell Biol; 2010 Aug; 30(16):4045-59. PubMed ID: 20547755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CtBP1 transactivates RAD51 and confers cisplatin resistance to breast cancer cells.
    Deng Y; Guo W; Xu N; Li F; Li J
    Mol Carcinog; 2020 May; 59(5):512-519. PubMed ID: 32124501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional regulation by C-terminal binding proteins.
    Chinnadurai G
    Int J Biochem Cell Biol; 2007; 39(9):1593-607. PubMed ID: 17336131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-Terminal Binding Protein 1 Modulates Cellular Redox via Feedback Regulation of MPC1 and MPC2 in Melanoma Cells.
    Deng Y; Li H; Yin X; Liu H; Liu J; Guo D; Shi Z
    Med Sci Monit; 2018 Oct; 24():7614-7624. PubMed ID: 30356033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CtBP1 overexpression in keratinocytes perturbs skin homeostasis.
    Deng H; Li F; Li H; Deng Y; Liu J; Wang D; Han G; Wang XJ; Zhang Q
    J Invest Dermatol; 2014 May; 134(5):1323-1331. PubMed ID: 24280726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-terminal binding protein-mediated transcriptional repression is regulated by X-linked inhibitor of apoptosis protein.
    Lee JS; Lee SK; Youn HD; Yoo SJ
    Biochem Biophys Res Commun; 2012 Jan; 417(1):175-81. PubMed ID: 22138398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zfp296 is a novel Klf4-interacting protein and functions as a negative regulator.
    Fujii Y; Kakegawa M; Koide H; Akagi T; Yokota T
    Biochem Biophys Res Commun; 2013 Nov; 441(2):411-7. PubMed ID: 24161396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-β1 downregulates AT1 receptor expression via PKC-δ-mediated Sp1 dissociation from KLF4 and Smad-mediated PPAR-γ association with KLF4.
    Zhang XH; Zheng B; Gu C; Fu JR; Wen JK
    Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):1015-23. PubMed ID: 22282354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.